Work

Clinical impact of PSMA PET in patients with biochemically recurrent prostate cancer after locoregional definitive therapy.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.e17009

Authors: Avanti Gulhane, Rafee Talukder, Atreya Dash, William J. Ellis, George Schade, Jonathan J. Chen, Emily Steinberger Weg, Heather H. Cheng, Petros Grivas, Jessica Hawley, John K. Lee, Robert B. Montgomery, Peter S. Nelson, Michael Thomas Schweizer, Todd Yezefski, Evan Y. Yu, Daniel W. Lin, Delphine L. Chen

Institutions: University of Washington, University of Washington Medical Center, Seattle Cancer Care Alliance, Fred Hutch Cancer Center, Columbia University Irving Medical Center

Language: English

Topic: Prostate Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Institute for Prostate Cancer Research

OpenAlex ID: W4281924549

Cites:

Cited by: 2

Related to: 10